We’re leading the charge against sarcopenic obesity! 📣 Dr. Scott Greilach, Senior Scientist at Immunis discusses published, pre-clinical data on how Immunis' human cell-derived secretome can potentially address #sarcopenic #obesity. Immunis' mission is to improve physical activity and quality of life as we age by reversing age-related muscle loss and metabolic dysfunction. Curious about how this innovation could transform health and longevity? Watch the full video titled “Stem Cell Secretome: A Game Changer in Reversing Sarcopenic Obesity” on our YouTube Channel! #healthinnovation #longevity #Immunis #clinicaltrials https://lnkd.in/guQq9_Si
Immunis, Inc.
Biotechnology Research
Irvine, California 1,272 followers
Developing innovative, stem cell-derived secretome therapies to reverse age-related diseases and immune dysfunction.
About us
Immunis Inc. is a private, clinical-stage biotechnology company developing stem cell-derived secretome therapies to address age-related diseases and immune dysfunction. The secretome is the total set of factors secreted from a cell including proteins, lipids, growth factors, cytokines, and exosomes. A well-functioning immune system is necessary for our health and secretomes can refine immune cell responses, making them a promising therapeutic for autoimmune, neurodegenerative and age-related muscle wasting diseases (sarcopenia). Our investigational secretome, IMMUNA, includes a balance of all-natural, clinical-grade factors that benefit immune system development, modulation, and health. Immunis’ published pre-clinical data in GeroScience demonstrates that IMMUNA benefits muscle regeneration, mass, and function. Immunis published additional data in Aging Cell showing that IMMUNA increases whole-body lean mass and reduces fat mass, while increasing muscle size, enhancing muscle regeneration, and improving muscle function. 100% of humans develop sarcopenia with age, which significantly impairs mobility and compromises quality of life. Preventing muscle loss and improving muscle recovery are currently unfulfilled medical needs. Immunis' first clinical trial is a Phase 1/2a study of the safety and tolerability of IMMUNA for elderly individuals who have age-related muscle atrophy. The trial is currently ongoing. Immunis was recently granted permission by the FDA to proceed with its Phase II clinical trial testing of IMMUNA in reversing sarcopenic obesity. Obesity rates have skyrocketed within the past few decades, with a heavy impact on the elderly population. Age-related obesity is strongly linked with additional health concerns including diabetes and muscle loss, which can have detrimental effects on quality of life. “Our innovative therapy shows promising results by simultaneously decreasing fat and enhancing muscle,” explains Chairman Dr. Keirstead.
- Website
-
www.immunisbiomedical.com
External link for Immunis, Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Irvine, California
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Sarcopenia, Muscle atrophy, Metabolism, Cell therapy, Secretome, human healthspan, Muscle health, and Obesity
Locations
-
Primary
Get directions
18301 Von Karman Ave
Irvine, California 92612, US
Employees at Immunis, Inc.
-
Mark Cabato, CFA
Biotech Executive + BioPharma Strategic Finance Professional Specializing in Business Development, Corporate Finance, and Life Science Valuation
-
Jim Brandt
Investor at SpaceX
-
Robert Cockrell, M.D.
Chairman, SAB Immunis Biomedical, Inc.
-
Scott Greilach
Research Scientist-Immunologist-Translational Stem Cell Biologist
Updates
-
Immunis, Inc. reposted this
Over 65 companies made significant announcements in September & October 2024, signaling a super active obesity market. Are you Up to date? Catailyst can keep you up to date! Try it here! https://lnkd.in/dZ2M7DZ9 📈 Clinical trials, regulatory updates, and collaborations dominated the scene. Aardvark Therapeutics, Inc. Allurion Technologies, Inc. Altimmune, Inc., Inc Amneal Pharmaceuticals, Inc. AMRA Medical Antag Therapeutics Arrowhead Pharmaceuticals, Inc. Ascletis Pharma Inc. Beijing QL Biopharmaceutical Research Company Co., Ltd. BioAge Labs, Inc. Biomea Fusion, Inc. Bio-Path Holdings, Inc. BioRestorative Therapies, Inc. Calocurb CinFina Pharma Convatec UK Corbus Pharmaceuticals Holdings, Inc. Currax Pharmaceuticals LLC Digbi Health EADV Eccogene Inc Entera Bio Ltd.; OPKO Health, Inc. E-Scopics Gnubiotics Sciences SA HAYA Therapeutics, SA Immunis, Inc. Ivim Health Kailera Therapeutics, Inc. Kallyope Kanazawa University Key Bioscience AG Laxxon Medical Lipocine Inc. MelliCell, Inc. Metabolic Health Solutions Metsera MitoRx Therapeutics Modular Medical, Inc. Moonwalk Biosciences NeuroBo Pharmaceuticals, Inc. Novo Nordisk Options Medical Weight Loss OrsoBio, Inc. Prime Therapeutics Rani Therapeutics, LLC Response Pharmaceuticals, Inc. Revival Health Inc. Rhythm Pharmaceuticals, Inc. Rivus Pharmaceuticals Scholar Rock Sema Slim, LLC Skinvisible, Inc. Skye Bioscience, Inc. Structure Therapeutics Inc. TCI Bio Technavio Terns Pharmaceuticals, Inc. True You Weight Loss, PLLC UEG Week Veru Inc. Vivani Medical, Inc. VIVUS LLC VSee Health, Inc. Wave Life Sciences USA, Inc. Xtalks
-
Immunis, Inc. reposted this
We are thrilled to highlight Karissa Muñoz, PhD, who is a Senior Scientific Communications Manager at Immunis, Inc. as our #Rootingforyou Ambassador 🥼 🎉 📖 Read below her leadership purpose and the experiences that inspire her mission: "I hope to be a leader to anyone who relates to my life experiences. I am a Mexican-American, first-generation college graduate and member of the LGBT+ community. I am proud to say that despite the limited representation in my life, I prioritized my education and received my doctorate. To this day, I have spoken to classrooms of high schoolers, many of whom are first generation-college students, in the hopes of inspiring them to be the greatest versions of themselves." We are #rootingforyou 👏 #leadership #biotech #empowerment #diversity #limitless #pharma
-
Innovation meets expertise: Don't miss Dr. Hans Keirstead's presentation at this year's hottest biotech event, BioFuture. 🚀💡📚 Join us in NYC and catch up on the latest biotech innovations and therapies that are changing the way we approach healthcare. 💊 🏨 Don't just witness the future – be part of it! 😎
-
-
#NextMedHealth brings together a diverse community of #innovators to discover and explore the cutting edge technologies of the future. 🧠 ✨ We are delighted that Chairman Dr. Hans Keirstead will be among the presenting faculty this year in San Diego. Join us as we learn 💬 , connect 👫 , collaborate 👥 , and help catalyze new solutions ✅ that can impact many of the challenges we face in #healthcare globally. NextMed Health is the evolution of Exponential Medicine, founded by Daniel Kraft, MD, and reimagines the art of the possible in health(care) and biomedicine in the emerging 'Health Age.' We hope to see you there! Join Now and register with the code FACULTY-FRIEND-250, to save $250 on top of current ‘early bird’ rates.
-
-
Immunis, Inc. reposted this
Ready to get my communication on!!! 🗣️📝 Learning so much about #AI #promptography at the Ragan Internal Communications Conference at Microsoft’s Headquarters. I can’t wait to bring this knowledge back to Immunis, Inc. Ragan Communications and PR Daily
-
-
The future of biotech is here, and our Chairman is leading the charge🔋💥🔌 If you'd like to learn about what a secretome is and how it may be the most groundbreaking tool in biotech, join us at the BioFuture conference in NYC. Dr. Hans Keirstead will share all the details from Immunis' latest secretome research and discuss how secretomes can be used to address an assortment of age and immune-related diseases. Join us at the forefront of innovation – your future self will thank you. 😉 Demy-Colton #biotech #innovation #technology #breakthroughs #researchandinnovation #pharmaceuticals #secretomes
-
-
🚨 Alert! Alert! 🚨 Spooky season is making way for something even more exciting! 🎃➡️🤓 It's conference time, baby! 🎉📚🖊️ That's right! Our very own Karissa Muñoz, PhD is heading to Seattle for Ragan's Internal Communications Conference! 🌟 And it's not just any venue - we're talking Microsoft HQ, people! 🖥️🏢 Are you a fellow science comm enthusiast? 🔬🗣️ Or maybe you're curious about the cool stuff happening at Immunis? 🧪🔬 Don't be shy! Message Karissa to chat! 💬 👏👏 We're turning this conference into a knowledge party! 🎊🧠 Who's in? #science #innovation #scientificcommunications #biotech #communications
-
-
Move over spooky season 🎃 Are you ready for conference season?! ✨📚🖌 Karissa Muñoz, PhD is thrilled to be attending Ragan's Internal Communications Conference hosted at the Microsoft's headquarters in Seattle. If you are interested in exchanging scientific communication strategies or learning more about Immunis, please message her! Ragan Communications and PR Daily #science #innovation #scientificcommunications #biotech #communications #startup
-
-
Check out our Immunis Star!!! 🌟😀🌟 We hope you enjoyed Dr. Scott Greilach's discussion of Immunis' innovative secretome therapy. We are proudly pursuing our investigations of the efficacy of the secretome in reversing muscle atrophy and improving metabolism in an FDA-approved Phase 2 clinical trial. Check out our website for more details. Thank you to Ruby F and the Drug Discoveries Strategic Summit team for putting together another great conference. 🎉 www.immunisbiomedcal.com #teamwork #scientificexploration #innovation #pharmaceuticals #secretome #biotech
-